ARCHIVES

Totality Of Evidence Causes Concern About New Findings.

This article is from The Cancer Letter archive.

Vol. 33 No. 45 | December 7, 2007

Download PDF Visit The Full Archive

Related Articles

Bevacizumab And Irinotecan May Increase Survival Of GBM

October 26, 2007

ASCO Writes A New Mission Statement Placing Emphasis On Helping Patients

May 21, 1999

Cancer Advocacy: Deal Returns $3M to Office of Women’s Health, Spends $3.5M On Workshops

August 1, 1997

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

September 6, 2002

Guest Editorial: Cancer from Fukushima? Is Sushi-Eating Over?

March 16, 2012

Foundations: Lasker Awards honor Work In Nitric Oxide, HIB Vaccine

October 4, 1996